IP Library Granted Patent US 7,943,362
Granted Patent B2
US 7,943,362 · App. 11/784,452 · Granted May 17, 2011

Biosynthesis of phloroglucinol and preparation of 1,3-dihydroxybenzene therefrom

Assignee: Board of Trustees of Michigan State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,943,362
App. No.
11/784,452
Granted
May 17, 2011
Kind
B2
Abstract

The present invention provides methods, enzymes, and cells for the biosynthetic production of phloroglucinol from malonyl-CoA, which is ultimately obtained from simple starting materials such as glucose; also provided are methods for preparing derivatives of biosynthetic phloroglucinol, including, e.g., resorcinol.

Claims (12)

1. A recombinant cell comprising a phloroglucinol synthase having the amino acid sequence of SEQ ID NO: 2, wherein the recombinant cell does not express other active enzymes involved in the acetylphloroglucinol synthesis pathway, the recombinant cell being capable of converting malonyl-CoA to phloroglucinol.

2. The recombinant cell according to claim 1 , wherein said recombinant cell further comprises at least one enzyme of the malonyl-CoA synthesis pathway.

3. The recombinant cell according to claim 2 , wherein the enzyme of the malonyl-CoA synthesis pathway is any one of malonyl-CoA synthetase, malonyl-CoA decarboxylase, or acetyl-CoA carboxylase.

4. The recombinant cell according to claim 1 , wherein the recombinant cell is a microbe.

5. The recombinant cell according to claim 4 , wherein the recombinant cell is a yeast, fungus, or bacterium.

6. The recombinant cell according to claim 5 , wherein the recombinant cell is a bacterium.

7. The recombinant cell according to claim 6 , wherein the recombinant cell is a member of any one of the genera Escherichia or Pseudomonas.

8. The recombinant cell according to claim 7 wherein the recombinant cell is any one of E. coli or P. fluorescens.

9. An isolated or recombinant nucleic acid vector comprising at least one open reading frame encoding a phloroglucinol synthase having the amino acid sequence of SEQ ID NO: 2, wherein said nucleic acid vector does not express at least one of other active enzymes involved in the acetylphloroglucinol synthesis pathway, and further comprises at least one open reading frame encoding an enzyme of the malonyl-CoA synthesis pathway.

10. The nucleic acid vector according to claim 9 , wherein said nucleic acid vector comprises the nucleic acid sequence of SEQ ID NO: 1, or a nucleic acid sequence encoding the amino acid sequence of SEQ ID NO: 2 and having at least one redundant codon therewith.

11. The nucleic acid vector according to claim 9 , wherein said nucleic acid vector comprises a nucleic acid sequence encoding SEQ ID NO: 2 which is at least 80% identical to SEQ ID NO: 1.

12. A process for the preparation of a recombinant cell that is capable of biosynthesizing phloroglucinol from malonyl-CoA, comprising transforming a cell with a nucleic acid encoding a phloroglucinol synthase having the amino acid sequence of SEQ ID NO: 2, wherein the recombinant cell does not express other active enzymes involved in the acetylphloroglucinol synthesis pathway.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 17, 2010
From: MICHIGAN STATE UNIVERSITY
To: NAVY, SECRETARY OF THE UNITED STATES OF AMERICA OFFICE OF NAVAL RESEARCH
Reel/Frame 025306/0810 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2007
From: FROST, JOHN W.
To: BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY
Reel/Frame 019228/0201 →
Continuity (4)
Continuation PCTUS2005036291 · Oct 11, 2005
Provisional Application 60617959 · Oct 12, 2004
Provisional Application 60618024 · Oct 12, 2004
Related Publication 20070178571A1 · Aug 2, 2007